Histone Deacetylase (HDAC) Inhibitors

Histone deacetylase (HDAC) inhibitors are a class of compounds that have gained significant attention in the field of epigenetics These inhibitors are designed to disrupt the activity of histone deacetylases which are enzymes responsible for removing acetyl groups from histone proteins By inhibiting HDACs these compounds can increase the acetylation of histones leading to changes in gene expression patterns This modulation of gene expression has been shown to have therapeutic potential in various diseases including cancer and neurodegenerative disorders Our company offers a range of highly effective HDAC inhibitors for scientific research and drug development purposes

Get A Quote

Products Application Supporting Data Resources Related Products

Products

Catalog Number	Chemical Name	CAS #	Price
BC-0476	Trichostatin A	58880-19-6	Online Inquiry
BC-0497	4-Iodo-SAHA	1219807-87-0	Online Inquiry
BC-0543	Coumarin-SAHA	1260635-77-5	Online Inquiry
BC-0584	HNHA	926908-04-5	Online Inquiry
BC-0585	HPOB	1429651-50-2	Online Inquiry
BC-0597	JGB1741	1256375-38-8	Online Inquiry
BC-0598	KD 5170	940943-37-3	Online Inquiry
EI-0061	4SC-202	1186222-89-8	Online Inquiry
EI-0097	Abexinostat	783355-60-2	Online Inquiry
EI-0120	ACY-1215	1316214-52-4	Online Inquiry
EI-0121	ACY-775	1375466-18-4	Online Inquiry
EI-0203	Apicidin	183506-66-3	Online Inquiry
EI-0214	AR-42 (HDAC-42)	935881-37-1	Online Inquiry
EI-0306	AZD-9468	934828-12-3	Online Inquiry
EI-0376	BG-45	926259-99-6	Online Inquiry

Application

Histone Deacetylase (HDAC) inhibitors are a powerful tool in the field of epigenetics research They are commonly used to investigate the role of histone acetylation in gene expression and regulation By inhibiting HDAC enzymes these inhibitors can promote histone acetylation leading to changes in chromatin structure and gene activity This enables scientists to study the impact of histone modifications on a wide range of biological processes including development differentiation and disease

In the field of medicine HDAC inhibitors hold great potential as therapeutic agents They have shown promise in the treatment of various cancers as they can inhibit the growth and proliferation of cancer cells Additionally HDAC inhibitors have been explored for their potential in neurodegenerative diseases as they can enhance memory and cognitive function

Furthermore HDAC inhibitors have been studied for their anti-inflammatory properties making them a potential treatment option for diseases characterized by chronic inflammation such as rheumatoid arthritis or inflammatory bowel disease Overall HDAC inhibitors offer exciting possibilities for both research and therapeutic applications in the field of biology

Supporting Data

Resources

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.